NO20014234D0 - Pyrazol-3-on-derivater som faktor-Xa-inhibitorer - Google Patents

Pyrazol-3-on-derivater som faktor-Xa-inhibitorer

Info

Publication number
NO20014234D0
NO20014234D0 NO20014234A NO20014234A NO20014234D0 NO 20014234 D0 NO20014234 D0 NO 20014234D0 NO 20014234 A NO20014234 A NO 20014234A NO 20014234 A NO20014234 A NO 20014234A NO 20014234 D0 NO20014234 D0 NO 20014234D0
Authority
NO
Norway
Prior art keywords
pyrazol
inhibitors
derivatives
factor
Prior art date
Application number
NO20014234A
Other languages
English (en)
Other versions
NO20014234L (no
Inventor
Dieter Dorsch
Horst Juraszyk
Werner Mederski
Christos Tsaklakidis
Hanns Wurziger
Sabine Bernotat-Danielowski
Guido Melzer
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20014234D0 publication Critical patent/NO20014234D0/no
Publication of NO20014234L publication Critical patent/NO20014234L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D231/08Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20014234A 1999-03-03 2001-08-31 Pyrazol-3-on-derivater som faktor-Xa-inhibitorer NO20014234L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19909237A DE19909237A1 (de) 1999-03-03 1999-03-03 Pyrazol-3-on-derivate
PCT/EP2000/001695 WO2000051989A1 (de) 1999-03-03 2000-02-29 Pyrazol-3-on-derivate als faktor xa inhibitoren

Publications (2)

Publication Number Publication Date
NO20014234D0 true NO20014234D0 (no) 2001-08-31
NO20014234L NO20014234L (no) 2001-10-24

Family

ID=7899522

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014234A NO20014234L (no) 1999-03-03 2001-08-31 Pyrazol-3-on-derivater som faktor-Xa-inhibitorer

Country Status (17)

Country Link
EP (1) EP1157010A1 (no)
JP (1) JP2002538143A (no)
KR (1) KR20010102428A (no)
CN (1) CN1342148A (no)
AU (1) AU2916500A (no)
BR (1) BR0008608A (no)
CA (1) CA2364908A1 (no)
CZ (1) CZ20013164A3 (no)
DE (1) DE19909237A1 (no)
HU (1) HUP0200242A3 (no)
MX (1) MXPA01008844A (no)
NO (1) NO20014234L (no)
PL (1) PL350941A1 (no)
RU (1) RU2001126566A (no)
SK (1) SK12152001A3 (no)
WO (1) WO2000051989A1 (no)
ZA (1) ZA200108064B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455525B1 (en) 1999-11-04 2002-09-24 Cephalon, Inc. Heterocyclic substituted pyrazolones
WO2004050637A2 (en) 2002-12-03 2004-06-17 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
WO2005012255A1 (ja) * 2003-08-01 2005-02-10 Mitsubishi Pharma Corporation 炎症性関節疾患の治療剤
DE102008020113A1 (de) 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituierte Dihydropyrazolone und ihre Verwendung
DE102005019712A1 (de) 2005-04-28 2006-11-09 Bayer Healthcare Ag Dipyridyl-dihydropyrazolone und ihre Verwendung
DE102006050513A1 (de) 2006-10-26 2008-04-30 Bayer Healthcare Ag Substitiuierte Dihydropyrazolone und ihre Verwendung
DE102006050515A1 (de) 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dipyridiyl-dihydropyrazolone und ihre Verwendung
DE102006050516A1 (de) 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dihydropyrazolone und ihre Verwendung
DE102007044032A1 (de) 2007-09-14 2009-03-19 Bayer Healthcare Ag Substituierte heterocyclische Verbindungen und ihre Verwendung
DE102007048447A1 (de) 2007-10-10 2009-04-16 Bayer Healthcare Ag Substituierte Dihydropyrazolthione und ihre Verwendung
DE102010044131A1 (de) 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612353A (en) * 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
JP3994453B2 (ja) * 1995-10-13 2007-10-17 日産化学工業株式会社 ピラゾロン類

Also Published As

Publication number Publication date
NO20014234L (no) 2001-10-24
SK12152001A3 (sk) 2002-03-05
CA2364908A1 (en) 2000-09-08
AU2916500A (en) 2000-09-21
JP2002538143A (ja) 2002-11-12
EP1157010A1 (de) 2001-11-28
PL350941A1 (en) 2003-02-24
MXPA01008844A (es) 2002-05-14
KR20010102428A (ko) 2001-11-15
CN1342148A (zh) 2002-03-27
HUP0200242A2 (hu) 2002-11-28
ZA200108064B (en) 2003-01-02
CZ20013164A3 (cs) 2001-12-12
RU2001126566A (ru) 2004-02-27
HUP0200242A3 (en) 2002-12-28
BR0008608A (pt) 2002-01-02
WO2000051989A1 (de) 2000-09-08
DE19909237A1 (de) 2000-09-07

Similar Documents

Publication Publication Date Title
NO20021239D0 (no) Pteridinoner som kinase-inhibitorer
NO20022139L (no) Kinazolinderivater som VEGF inhibitorer
EE200300049A (et) Imidasooli derivaadid
NO20023828L (no) Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer
DE60009747D1 (de) Admantan-derivate
ATE360620T1 (de) Imidazolderivate
NO20015065D0 (no) Pyrazolobenzodiazepiner som CDK2-inhibitorer
DE50010060D1 (de) Thiazolylamid-derivate
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
PT1237857E (pt) Novos derivados fenalquiloxi-fenilo
ATE257148T1 (de) Propargyletherderivate
NO20035440D0 (no) Pyrrolidinderivater som faktor-XA-inhibitorer
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
ATE374747T1 (de) Monofluoralkylderivate
DK1154988T3 (da) Mevinolinderivater
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
NO20021959L (no) Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer
NO20014234D0 (no) Pyrazol-3-on-derivater som faktor-Xa-inhibitorer
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de) Resorcinderivate
NO20023001D0 (no) Substituerte piperazinderivater som MTP inhibitorer
DK1222193T3 (da) Imidazolderivater som phosphodiesterase VII-inhibitorer
DE60025348D1 (de) Ethansulfonyl-piperidin-derivate
DE60001736D1 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application